Correlating skin toxicity and steroid treatment with outcomes of anti-PD-1 therapy for patients with metastatic melanoma

被引：0
|
作者：
Quach, Henry T. [1 ]
Johnson, Douglas B. [2 ]
Dewan, Anna K. [3 ]
机构：
[1] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA
[2] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA
[3] Vanderbilt Univ, Med Ctr, Dept Dermatol, Nashville, TN USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2019年 / 81卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
10388
引用
收藏
页码：AB39 / AB39
页数：1
相关论文
共 50 条
  • [21] Outcomes of adjuvant therapy with anti-PD-1 antibody for mucosal melanoma
    Okumura, M.
    Ogata, D.
    Namikawa, K.
    Nakano, E.
    Omura, G.
    Honma, Y.
    Ishiyama, K.
    Tsukamoto, S.
    Matsui, Y.
    Ishikawa, M.
    Suzuki, S.
    Kanemitsu, Y.
    Daiko, H.
    Yoshimoto, S.
    Kato, K.
    Yamazaki, N.
    ANNALS OF ONCOLOGY, 2024, 35 : S1339 - S1339
  • [22] Autoimmune hemolytic anemia induced by anti-PD-1 therapy in metastatic melanoma
    Kong, Benjamin Y.
    Micklethwaite, Kenneth P.
    Swaminathan, Sanjay
    Kefford, Richard F.
    Carlino, Matteo S.
    MELANOMA RESEARCH, 2016, 26 (02) : 202 - 204
  • [23] Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
    Hugo, Willy
    Zaretsky, Jesse M.
    Sun, Lu
    Song, Chunying
    Moreno, Blanca Homet
    Hu-Lieskovan, Siwen
    Berent-Maoz, Beata
    Pang, Jia
    Chmielowski, Bartosz
    Cherry, Grace
    Seja, Elizabeth
    Lomeli, Shirley
    Kong, Xiangju
    Kelley, Mark C.
    Sosman, Jeffrey A.
    Johnson, Douglas B.
    Ribas, Antoni
    Lo, Roger S.
    CELL, 2016, 165 (01) : 35 - 44
  • [24] Efficacy of ipilimumab after anti-PD-1 therapy in sequential treatment of metastatic melanoma patients - Real world evidence
    Cybulska-Stopa, Bozena
    Rogala, Pawel
    Czarnecka, Anna M.
    Lugowska, Iwona
    Teterycz, Pawel
    Galus, Lukasz
    Rajczykowski, Marcin
    Dawidowska, Anna
    Piejko, Karolina
    Suwinski, Rafal
    Mackiewicz, Jacek
    Rutkowski, Piotr
    ADVANCES IN MEDICAL SCIENCES, 2020, 65 (02): : 316 - 323
  • [25] Comparison of the efficacy and toxicity of anti-PD-1 monoclonal antibodies (nivolumab versus pembrolizumab) in treatment of patients with metastatic melanoma.
    Cybulska-Stopa, Bozena
    Zietek, Marcin
    Czarnecka, Anna Malgorzata
    Piejko, Karolina
    Dziura, Robert
    Galus, Lukasz
    Ziolkowska, Barbara
    Kieszko, Stanislaw
    Kempa-Kaminska, Natasza
    Calik, Jacek
    Gajewska-Wicher, Katarzyna
    Gadek, Kamila
    Salek-Zan, Agata
    Seredynska, Joanna
    Drosik-Kwasniewska, Anna
    Kaminska-Winciorek, Grazyna
    Kubiatowski, Tomasz
    Suwinski, Rafal
    Mackiewicz, Jacek
    Rutkowski, Piotr
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [26] Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma
    Jansen, Y. J. L.
    Rozeman, E. A.
    Mason, R.
    Goldinger, S. M.
    Foppen, M. H. Geukes
    Hoejberg, L.
    Schmidt, H.
    van Thienen, J., V
    Haanen, J. B. A. G.
    Tiainen, L.
    Svane, I. M.
    Makela, S.
    Seremet, T.
    Arance, A.
    Dummer, R.
    Bastholt, L.
    Nyakas, M.
    Straume, O.
    Menzies, A. M.
    Long, G., V
    Atkinson, V
    Blank, C. U.
    Neyns, B.
    ANNALS OF ONCOLOGY, 2019, 30 (07) : 1154 - 1161
  • [27] Response and skin toxicity related protein signature in late stage melanoma patients after anti-PD-1 treatment.
    Vowinckel, Jakob
    Mallardo, Domenico
    Sklodowski, Kamil
    Soste, Martin
    Capone, Mariaelena
    Madonna, Gabriele
    Vanella, Vito
    Warren, Sarah
    Beeler, Kristina
    Ascierto, Paolo A.
    CANCER RESEARCH, 2021, 81 (13)
  • [28] Treatment Options for Advanced Melanoma After Anti-PD-1 Therapy
    Babacan, Nalan Akgul
    Eroglu, Zeynep
    CURRENT ONCOLOGY REPORTS, 2020, 22 (04)
  • [29] Treatment Options for Advanced Melanoma After Anti-PD-1 Therapy
    Nalan Akgul Babacan
    Zeynep Eroglu
    Current Oncology Reports, 2020, 22
  • [30] Anti-PD-1 antibody treatment for melanoma
    Ribas, Antoni
    Kirkwood, John M.
    Flaherty, Keith T.
    LANCET ONCOLOGY, 2018, 19 (05): : E219 - E219
12345